Skip to main content
PMC home page
Applied Microbiology logoLink to Applied Microbiology
. 1971 Dec;22(6):1147–1151. doi: 10.1128/am.22.6.1147-1151.1971

Tobramycin (Nebramycin Factor 6): In Vitro Activity Against Pseudomonas aeruginosa1

R D Meyer 1, L S Young 1, D Armstrong 1
PMCID: PMC376501  PMID: 5002900

Abstract

Tobramycin (factor 6 of the nebramycin complex) is a new aminoglycoside antibiotic isolated from Streptomyces tenebrarius which is active against S. aureus, Enterobacteriaceae, and Pseudomonas aeruginosa. Susceptibility to tobramycin of 96 strains of P. aeruginosa, including 45 recent isolates from blood, was studied by using agar and broth dilution methods. The minimum inhibitory concentration (MIC) for 83 of 96 strains was 3.12 μg/ml or lower in Mueller Hinton agar; MIC values were two to eight times lower in Mueller Hinton broth tests. Agar dilution MIC values were generally lower than those obtained in parallel tests with gentamicin. Killing curves obtained from serial sampling of broth cultures showed a 100- to 10,000-fold decline in viability of log-phase organisms within 30 min of exposure to the drug. Two-dimensional agar dilution tests with carbenicillin and tobramycin with 79 strains showed additive or synergistic effects; no antagonism was documented. Seventy-eight of 79 strains were inhibited by a combination of 50 μg of carbenicillin per ml and 1.56 μg of tobramycin per ml, blood levels which seem attainable in man. Tobramycin appears to be a potent, rapidly bactericidal antibiotic against P. aeruginosa and merits clinical evaluation.

Full text

PDF
1150

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler J. L., Burke J. P., Finland M. Infection and antibiotic usage at Boston City Hospital, January 1970. Arch Intern Med. 1971 Mar;127(3):460–465. [PubMed] [Google Scholar]
  2. Armstrong D., Young L. S., Meyer R. D., Blevins A. H. Infectious complications of neoplastic disease. Med Clin North Am. 1971 May;55(3):729–745. doi: 10.1016/s0025-7125(16)32514-7. [DOI] [PubMed] [Google Scholar]
  3. BRAYTON R. G., LOURIA D. B. GENTAMICIN IN GRAM-NEGATIVE URINARY AND PULMONARY INFECTIONS. Arch Intern Med. 1964 Aug;114:205–212. doi: 10.1001/archinte.1964.03860080055004. [DOI] [PubMed] [Google Scholar]
  4. Bodey G. P., Terrell L. M. In vitro activity of carbenicillin against gram-negative bacilli. J Bacteriol. 1968 May;95(5):1587–1590. doi: 10.1128/jb.95.5.1587-1590.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brumfitt W., Percival A., Leigh D. A. Clinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea. Lancet. 1967 Jun 17;1(7503):1289–1293. doi: 10.1016/s0140-6736(67)91590-5. [DOI] [PubMed] [Google Scholar]
  6. Eickhoff T. C. In vitro effects of carbenicillin combined with gentamicin or polymyxin B against Pseudomonas aeruginosa. Appl Microbiol. 1969 Sep;18(3):469–473. doi: 10.1128/am.18.3.469-473.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hahn F. E., Sarre S. G. Mechanism of action of gentamicin. J Infect Dis. 1969 Apr-May;119(4):364–369. doi: 10.1093/infdis/119.4-5.364. [DOI] [PubMed] [Google Scholar]
  8. Higgins C. E., Kastner R. E. Nebramycin, a new broad-spectrum antibiotic complex. II. Description of Streptomyces tenebrarius. Antimicrob Agents Chemother (Bethesda) 1967;7:324–331. [PubMed] [Google Scholar]
  9. Kirby W. M., Standiford H. C. Gentamicin: in vitro studies. J Infect Dis. 1969 Apr-May;119(4):361–363. doi: 10.1093/infdis/119.4-5.361. [DOI] [PubMed] [Google Scholar]
  10. LOEWE S. The problem of synergism and antagonism of combined drugs. Arzneimittelforschung. 1953 Jun;3(6):285–290. [PubMed] [Google Scholar]
  11. MacMillan B. G. Gentamicin in the management of thermal injuries. J Infect Dis. 1969 Apr-May;119(4):492–503. doi: 10.1093/infdis/119.4-5.492. [DOI] [PubMed] [Google Scholar]
  12. Martin C. M., Cuomo A. J., Geraghty M. J., Zager J. R., Mandes T. C. Gram-negative rod bacteremia. J Infect Dis. 1969 Apr-May;119(4):506–517. doi: 10.1093/infdis/119.4-5.506. [DOI] [PubMed] [Google Scholar]
  13. McLaughlin J. E., Reeves D. S. Clinical and laboratory evidence for inactivation of gentamicin by carbenicillin. Lancet. 1971 Feb 6;1(7693):261–264. doi: 10.1016/s0140-6736(71)91001-4. [DOI] [PubMed] [Google Scholar]
  14. RIFKIND D., MARCHIORO T. L., WADDELL W. R., STARZL T. E. INFECTIOUS DISEASES ASSOCIATED WITH RENAL HOMOTRANSPLANTATION. JAMA. 1964 Aug 10;189:397–407. doi: 10.1001/jama.1964.03070060007001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Smith C. B., Dans P. E., Wilfert J. N., Finland M. Use of gentamicin in combinations with other antibiotics. J Infect Dis. 1969 Apr-May;119(4):370–377. doi: 10.1093/infdis/119.4-5.370. [DOI] [PubMed] [Google Scholar]
  16. Smith C. B., Finland M. Carbenicillin: activity in vitro and absorption and excretion in normal young men. Appl Microbiol. 1968 Nov;16(11):1753–1760. doi: 10.1128/am.16.11.1753-1760.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sonne M., Jawetz E. Combined action of carbenicillin and gentamicin on Pseudomonas aeruginosa in vitro. Appl Microbiol. 1969 Jun;17(6):893–896. doi: 10.1128/am.17.6.893-896.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Stark W. M., Hoehn M. M., Knox N. G. Nebramycin, a new broad-spectrum antibiotic complex. I. Detection and biosynthesis. Antimicrob Agents Chemother (Bethesda) 1967;7:314–323. [PubMed] [Google Scholar]
  19. Thompson R. Q., Presti E. A. Nebramycin, a new broad-spectrum antibiotic complex. 3. Isolation and chemical-physical properties. Antimicrob Agents Chemother (Bethesda) 1967;7:332–340. [PubMed] [Google Scholar]
  20. Wick W. E., Welles J. S. Nebramycin, a new broad-spectrum antibiotic complex. IV. In vitro and in vivo laboratory evaluation. Antimicrob Agents Chemother (Bethesda) 1967;7:341–348. doi: 10.1128/AAC.7.3.341. [DOI] [PubMed] [Google Scholar]
  21. Young L. S., Louria D. B., Armstrong D. Gentamicin in the treatment of severe, hospital-acquired gram-negative infections. Trans N Y Acad Sci. 1967 Mar;29(5):579–588. doi: 10.1111/j.2164-0947.1967.tb02428.x. [DOI] [PubMed] [Google Scholar]

Articles from Applied Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES